{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 157,
  "pageCount": 239,
  "prevPage": 156,
  "nextPage": 158,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Uses red boxes to highlight 'diabetic neuropathy' or 'peripheral neuropathy' in various insurance policy documents.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "screenshot"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/157",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-157",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "One can easily search online for insurance authorization forms, which already include PDN as a typical indication and reimbursement category for spinal cord stimulation.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b343-369eb6d9b4a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.8,
        "x": 0.06,
        "y": 0.22
      },
      "kind": "other",
      "text": "Aetna, Health Partners, One of many state BCBS plans, PEHP",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1b5bd742-f2fd-41ad-9762-f73661337925",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.9,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "One can easily search online for insurance authorization forms, which already include PDN as a typical indication and reimbursement category for spinal cord stimulation. Examples -",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "822727fb-1323-43a2-942c-d387fcb4eee8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.06,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Source: http://www.aetna.com/cpb/medical/data/100_199/0194.html; https://www.pehp.org/mango/pdf/pehp/pdc/spinalcordstim_fe3203a6.pdf; https://www.healthpartners.com/ucm/groups/public/@hp/@public/@cc/documents/dev_058770.pdf; https://www.bcbst.com/mpmanual/spinal_cord_stimulation_for_treatment_of_pain.htm",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "09f77f57-b3d3-4a2a-b3ce-9d3e8c1a1503",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.85,
        "x": 0.06,
        "y": 0.09
      },
      "kind": "title",
      "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c2a03b58-de11-4d9a-b966-1715123b938f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0fbb61a2-0b09-49c7-886e-e18fd75ec517",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "865fcdb4-b794-4853-a60b-19b6e6e951c8",
      "evidence": "Exposing company claims as a 'mirage' using primary source documentation.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}